▶ 調査レポート

世界の核医学/放射性医薬品産業2020-2026

• 英文タイトル:Global Nuclear Medicine/Radiopharmaceuticals Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界の核医学/放射性医薬品産業2020-2026 / Global Nuclear Medicine/Radiopharmaceuticals Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3012493資料のイメージです。• レポートコード:D0MA3012493
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥539,000 (USD4,900)▷ お問い合わせ
  Multi User¥808,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,078,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、核医学/放射性医薬品の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、核医学/放射性医薬品のグローバル市場動向、メーカー別競争状況、種類別市場規模(診断、治療薬)、用途別市場規模(腫瘍学、甲状腺、心臓病学)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・核医学/放射性医薬品の種類別市場2015-2026:診断、治療薬
・核医学/放射性医薬品の用途別市場2015-2026:腫瘍学、甲状腺、心臓病学
・核医学/放射性医薬品の北米市場分析
・核医学/放射性医薬品のアジア市場分析
・核医学/放射性医薬品の中南米市場分析
・核医学/放射性医薬品の中東・アフリカ市場分析
・関連企業情報:China Isotope & Radiation、Dongcheng、Jaco、Ciaeriar、Advanced Molecular-imaging Solution、Shanghai Atom Kexing
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In 2019, the global Nuclear Medicine/Radiopharmaceuticals market size was US$ 5435.6 million and is forecast to US$ 9475.7 million in 2026, growing at a CAGR of 8.2% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Nuclear Medicine/Radiopharmaceuticals.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Nuclear Medicine/Radiopharmaceuticals market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Nuclear Medicine/Radiopharmaceuticals market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Nuclear Medicine/Radiopharmaceuticals market. Readers of the report can become informed about current and future trends of the global Nuclear Medicine/Radiopharmaceuticals market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Nuclear Medicine/Radiopharmaceuticals markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Nuclear Medicine/Radiopharmaceuticals market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Nuclear Medicine/Radiopharmaceuticals market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Nuclear Medicine/Radiopharmaceuticals market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Nuclear Medicine/Radiopharmaceuticals market is segmented into
Diagnostic
Therapeutic

Market Segment by Application, the Nuclear Medicine/Radiopharmaceuticals market is segmented into
Oncology
Thyroid
Cardiology

This report includes the following manufacturers; we can also add the other companies as you want.
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing

The study objectives are:
To analyze and research the global Nuclear Medicine/Radiopharmaceuticals status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Nuclear Medicine/Radiopharmaceuticals manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceuticals are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Nuclear Medicine/Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Market Segment by Application
1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Oncology
1.4.3 Thyroid
1.4.4 Cardiology
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue (2015-2026)
2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue (2015-2026)
2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales (2015-2026)
2.2 Nuclear Medicine/Radiopharmaceuticals Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions (2015-2020)
2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions (2015-2020)
2.3 Global Top Nuclear Medicine/Radiopharmaceuticals Regions (Countries) Ranking by Market Size
2.4 Nuclear Medicine/Radiopharmaceuticals Industry Trends
2.4.1 Nuclear Medicine/Radiopharmaceuticals Market Top Trends
2.4.2 Market Drivers
2.4.3 Nuclear Medicine/Radiopharmaceuticals Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Nuclear Medicine/Radiopharmaceuticals Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers by Sales (2015-2020)
3.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Nuclear Medicine/Radiopharmaceuticals Sales in 2019
3.2 Global Top Manufacturers Nuclear Medicine/Radiopharmaceuticals by Revenue
3.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nuclear Medicine/Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019)
3.4 Global Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
3.7 Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Nuclear Medicine/Radiopharmaceuticals Historic Market Review by Type (2015-2020)
4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.1.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
4.1.4 Nuclear Medicine/Radiopharmaceuticals Price by Type (2015-2020)
4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.4 Nuclear Medicine/Radiopharmaceuticals Price Forecast by Type (2021-2026)

5 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application
5.1 Global Nuclear Medicine/Radiopharmaceuticals Historic Market Review by Application (2015-2020)
5.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5.1.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
5.1.4 Nuclear Medicine/Radiopharmaceuticals Price by Application (2015-2020)
5.2 Global Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.4 Nuclear Medicine/Radiopharmaceuticals Price Forecast by Application (2021-2026)

6 North America
6.1 North America Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Company
6.2 North America Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Type
6.3 North America Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Application
6.4 North America Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Countries
6.4.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries
6.4.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Company
7.2 Europe Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Type
7.3 Europe Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Application
7.4 Europe Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Countries
7.4.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries
7.4.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Company
8.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Type
8.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Application
8.4 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Regions
8.4.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Regions
8.4.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Company
9.2 Latin America Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Type
9.3 Latin America Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Application
9.4 Latin America Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Countries
9.4.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Countries
9.4.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Type
10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Application
10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Countries
10.3.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries
10.3.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 China Isotope & Radiation
11.1.1 China Isotope & Radiation Corporation Information
11.1.2 China Isotope & Radiation Business Overview and Total Revenue (2019 VS 2018)
11.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products and Services
11.1.5 China Isotope & Radiation SWOT Analysis
11.1.6 China Isotope & Radiation Recent Developments
11.2 Dongcheng
11.2.1 Dongcheng Corporation Information
11.2.2 Dongcheng Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Products and Services
11.2.5 Dongcheng SWOT Analysis
11.2.6 Dongcheng Recent Developments
11.3 Jaco
11.3.1 Jaco Corporation Information
11.3.2 Jaco Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Products and Services
11.3.5 Jaco SWOT Analysis
11.3.6 Jaco Recent Developments
11.4 Ciaeriar
11.4.1 Ciaeriar Corporation Information
11.4.2 Ciaeriar Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Products and Services
11.4.5 Ciaeriar SWOT Analysis
11.4.6 Ciaeriar Recent Developments
11.5 Advanced Molecular-imaging Solution
11.5.1 Advanced Molecular-imaging Solution Corporation Information
11.5.2 Advanced Molecular-imaging Solution Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Products and Services
11.5.5 Advanced Molecular-imaging Solution SWOT Analysis
11.5.6 Advanced Molecular-imaging Solution Recent Developments
11.6 Shanghai Atom Kexing
11.6.1 Shanghai Atom Kexing Corporation Information
11.6.2 Shanghai Atom Kexing Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Products and Services
11.6.5 Shanghai Atom Kexing SWOT Analysis
11.6.6 Shanghai Atom Kexing Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Nuclear Medicine/Radiopharmaceuticals Sales Channels
12.2.2 Nuclear Medicine/Radiopharmaceuticals Distributors
12.3 Nuclear Medicine/Radiopharmaceuticals Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
13.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions (2021-2026)
13.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
13.2.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
13.2.3 North America Nuclear Medicine/Radiopharmaceuticals Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
13.3.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
13.3.3 Europe Nuclear Medicine/Radiopharmaceuticals Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
13.4.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
13.5.2 Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
13.5.3 Latin America Nuclear Medicine/Radiopharmaceuticals Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Nuclear Medicine/Radiopharmaceuticals Key Market Segments
Table 2. Ranking of Global Top Nuclear Medicine/Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Diagnostic
Table 5. Major Manufacturers of Therapeutic
Table 6. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application 2019-2025 (K Units)
Table 7. Global Nuclear Medicine/Radiopharmaceuticals Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions 2015-2020 (K Units)
Table 9. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions 2015-2020
Table 10. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions 2015-2020
Table 12. Top Nuclear Medicine/Radiopharmaceuticals Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Nuclear Medicine/Radiopharmaceuticals Key Drivers: Impact Analysis (2021-2026)
Table 15. Nuclear Medicine/Radiopharmaceuticals Key Challenges
Table 16. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceuticals Players: Views for Future
Table 17. Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 19. Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 21. Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019)
Table 23. Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 24. Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Plants/Factories Distribution
Table 25. Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Area Served
Table 26. Date of Key Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
Table 27. Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Diagnostic Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global Therapeutic Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 32. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 33. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Type (2015-2020)
Table 35. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2021-2026)
Table 36. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2021-2026)
Table 37. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2021-2026)
Table 39. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Type (2021-2026)
Table 40. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 41. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 42. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Nuclear Medicine/Radiopharmaceuticals Price by Application 2015-2020 (USD/Unit)
Table 44. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 45. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 46. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2021-2026)
Table 48. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Application (2021-2026)
Table 49. North America Nuclear Medicine/Radiopharmaceuticals Sales by Company (2015-2020) (K Units)
Table 50. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 51. North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 52. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 53. North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 54. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 55. North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 56. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 57. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 59. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Company (2015-2020) (K Units)
Table 60. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 61. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 62. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 63. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 64. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 65. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 66. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 67. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Company (2015-2020) (K Units)
Table 80. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 81. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 82. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 83. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 84. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 85. Latin America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 87. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 97. China Isotope & Radiation Company Details
Table 98. China Isotope & Radiation Description and Business Overview
Table 99. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020)
Table 101. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales Market Share in Global Market
Table 102. China Isotope & Radiation Recent Development
Table 103. Dongcheng Company Details
Table 104. Dongcheng Description and Business Overview
Table 105. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020)
Table 107. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales Market Share in Global Market
Table 108. Dongcheng Recent Development
Table 109. Jaco Company Details
Table 110. Jaco Description and Business Overview
Table 111. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Jaco Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020)
Table 113. Jaco Nuclear Medicine/Radiopharmaceuticals Sales Market Share in Global Market
Table 114. Jaco Recent Development
Table 115. Ciaeriar Company Details
Table 116. Ciaeriar Description and Business Overview
Table 117. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020)
Table 119. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales Market Share in Global Market
Table 120. Ciaeriar Recent Development
Table 121. Advanced Molecular-imaging Solution Company Details
Table 122. Advanced Molecular-imaging Solution Description and Business Overview
Table 123. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020)
Table 125. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales Market Share in Global Market
Table 126. Advanced Molecular-imaging Solution Recent Development
Table 127. Shanghai Atom Kexing Company Details
Table 128. Shanghai Atom Kexing Description and Business Overview
Table 129. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020)
Table 131. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales Market Share in Global Market
Table 132. Shanghai Atom Kexing Recent Development
Table 133. Nuclear Medicine/Radiopharmaceuticals Distributors List
Table 134. Nuclear Medicine/Radiopharmaceuticals Customers List
Table 135. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 136. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type 2021-2026 (K Units)
Table 137. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application 2021-2026 (K Units)
Table 138. Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions 2021-2026 (K Units)
Table 139. Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions 2021-2026 (Million US$)
Table 140. North America Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Countries 2021-2026 (K Units)
Table 141. North America Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Countries 2021-2026
Table 142. Europe Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Countries 2021-2026 (K Units)
Table 143. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share Forecast by Countries 2021-2026
Table 144. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions 2021-2026 (K Units)
Table 145. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions 2021-2026 (Million US$)
Table 146. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Countries 2021-2026 (K Units)
Table 147. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Countries 2021-2026 (Million US$)
Table 148. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions 2021-2026 (K Units)
Table 149. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Regions 2021-2026 (Million US$)
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Shar by Type 2015-2026
Figure 3. Diagnostic Figures
Figure 4. Therapeutic Figures
Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019 & 2026
Figure 6. Oncology Use Case
Figure 7. Thyroid Use Case
Figure 8. Cardiology Use Case
Figure 9. Nuclear Medicine/Radiopharmaceuticals Report Years Considered
Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Market Size 2015-2026 (Million US$)
Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Sales 2015-2020 (K Units)
Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Market Size Market Share by Regions 2015-2020
Figure 13. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions in 2019
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers in 2019
Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Medicine/Radiopharmaceuticals Sales in 2019
Figure 17. Nuclear Medicine/Radiopharmaceuticals Value Share by Manufacturers in 2019
Figure 18. Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers In 2019
Figure 19. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2015-2020)
Figure 21. Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019
Figure 22. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Price Range (2015-2020)
Figure 23. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2015-2020)
Figure 24. Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019
Figure 25. North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 26. U.S. Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 28. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. Germany Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 31. U.K. Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 32. Italy Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 33. Russia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 34. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. China Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 36. Japan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 37. South Korea Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 38. India Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 39. Australia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 40. Taiwan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 41. Indonesia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 42. Thailand Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 43. Malaysia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 44. Philippines Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 45. Vietnam Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 46. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 47. Mexico Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 48. Brazil Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 49. Argentina Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 50. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Turkey Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 52. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.A.E Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 54. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Jaco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Ciaeriar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Advanced Molecular-imaging Solution Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Shanghai Atom Kexing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Nuclear Medicine/Radiopharmaceuticals Value Chain
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. North America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 64. North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 65. Europe Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 66. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 67. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 68. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 69. Latin America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 70. Latin America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 71. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 72. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed